Movement Disorder Sessions at the 12th EAN Congress
Geneva, Switzerland • June 27 - 30, 2026
The Following Sessions are offered in Partnership with the European Academy of Neurology (EAN).
Register now Full conference details
Use the hashtag #MDSatEAN to share your experience at the EAN Congress.
Day 1: Saturday, June 27, 2026
Symposium:
Tremor syndromes: From pathophysiology to emerging treatment approaches
10:30 - 12:30 CEST • Main Auditorium
Chairs: Roberto Erro, Antonella Macerollo
- Pathophysiology of tremor syndromes - Rich Helmich, The Netherlands
- Diagnostic criteria and clinical approach to tremor syndromes - Maria Stamelou, Greece
- Pharmacological and other, non-surgical, treatments of tremor syndromes - Roberto Erro, Italy
- Surgical options for tremor syndromes: Clinical indications, efficacy and safety - Antonella Macerollo, United Kingdom
|
Special Session: 15:30 – 17:00 CEST • Main Auditorium 
C. David Marsden Award Lecture
Bastiaan R. Bloem – Nijmegen, Netherlands
Dystonia Europe David Marsden Award Video Case Session Video Cases to be announced. |
Day 2: Sunday, June 28, 2026
Focused Workshop:
Current role and future perspectives of neuromodulation in the treatment of Parkinson's disease and dementia with Lewy bodies
8:30 - 10:00 CEST • Room Lisbon
Chair: Elena Moro
- Current role and future perspectives of deep brain stimulation in the treatment of PD – Elena Moro, France
- Focused ultrasound brain therapy is a new tool in the box – Günther Deuschl, Germany
- Potential of non-invasive brain stimulation (NIBS) for the treatment of PD and DLB – Irena Rektorova, Czech Republic
Teaching course - Level 2
Spectrum of dementia and movement disorders
15:30 - 18:40 CEST • Room Lisbon
- Frontotemporal dementia – Amytrophic lateral sclerosis spectrum
- Lewy Body Dementia and Parkinson’s Disease Dementia
- Clinical approach to complex phenotypes with cognitive impairment and movement disorders
- Imaging and fluid biomarkers in diagnosis of dementia
Hands-on course - Level 2
Botulinum toxin in neurological practice: A hands-on approach
17:30 - 19:00 CEST • Hands-on Course Room
- Ultrasound-guided demonstration (mannequin)
- Botulinum Toxin Injection techniques with and without EMG guidance
- Video demonstrations (Case-based learning)
Day 3: Monday, June 29, 2025
Focused Workshop:
Repurposing GLP-1 receptor agonists: A new frontiers for neuroprotection in neurological diseases
08:30 - 10:00 CEST • Room Lisbon
Chair: Federica Ferrari
- Beyond glycemic control: Uncovering the neuroprotective role of GLP-1 receptor agonists - Federica Ferrari, Italy
- GLP-1 receptor agonists in neurodegenerative diseases: What have we learned so far? – Dilan Athauda, United Kingdom
- GLP-1 receptor agonists for the treatment and prevention of stroke – Ellen Vercalsteren, Sweden
Symposium
Dementia with Lewy bodies: Current and future perspectives
11:00 - 12:30 CEST • Room Olso
Chairs: Irena Rektorova, Dag Aarsland
- Diagnosis of DLB within the framework of neuronal Lewy body diseases - Evelien Lemstra, The Netherlands
- Role of imaging in the assessment of neurodegeneration, longitudinal monitoring and target engagement - Daniel Ferreira, Sweden
- Neurophysiological biomarkers for disease stratification and longitudinal assessment - Laura Bonanni, Italy
- Treatment pathways, current and future perspectives - Dag Aarsland, United Kingdom
Interactive Session:
Pediatric and Early-on-set Movement Disorders in Daily Practice
Coordinated by MDS Young Members Group and EAN RRFS
11:00 - 12:30 CEST • Room Oslo
Chair: Giovanni Palermo
- Early-onset hypokinetic movement disorders – Giovanni Palermo, Italy
- Early-onset hyperkinetic movement disorders – Vanessa Carvalho, Portugal
- Movement disorders in children – H. Wieke Eggink, The Netherlands
Hands-on course - Level 2
Infusion therapies management in advanced Parkinson’s disease
11:00 - 12:30 CEST • HOC Room
- Continuous subcutaneous apomorphine infusion: Clinical indications and management
- Levodopa/carbidopa intestinal gel infusion: Clinical indications and management
- Levodopa/carbidopa Continuous subcutaneous infusion: Clinical indications and management
Cased-based workshop
Tell me how you speak and I will tell you your neurological disease: A case-based journey across neurodegeneration
11:00 - 12:30 CEST • Case-based Workshop room
Chair: Antonio Suppa
- Patient with Bulbar Dysarthria - Susanne Petri – Germany
- Patient with hypophonia and monotonous speech: Parkinson, atypical parkinsonism, or depression? - Antonio Suppa, Italy
- Patient with cognitive-linguistic speech impairment: FTD, Alzheimer’s disease of psychogenic? – Jordi A. Matias-Guiu - Spain
Day 4: Tuesday, June 30, 2026
Hands On Course (BYO Laptop):
How to interpret genetic variants and genetic reports in neurological disorders
8:30 - 10:00 CEST • Geneva Room
- Variant types, frequency in population and disease datasets, and conservation assessment
- In silico pathogenicity prediction tools and the ACMG/AMP variant interpretation guidelines
- The basics of a genetic report
Teaching course - Level 3
Synucleinopathies: Current and future treatment strategies
13:30 - 17:00 CEST • Copenhagen Room
Chair: Carlo Colosimo
- Current Concept of synucleinopathies in the era of biomarkers - Tiago Outeiro, Germany
- Management of motor symptoms in early and advanced Parkinson’s disease - Carlo Colosimo, Italy
- Dementia with Lewy Bodies: Identification and treatment - Milica Gregoric Kramberger, Slovenia
- Diagnose, cure and care for Multiple System Atrophy - Alessandra Fanciulli, Austria
MDS members are invited to use the hashtag #MDSatEAN to share their experience at the EAN Congress.
Visit the 12th EAN Congress Website for additional information or to register.